Video Center


The OBR Video Center Features educational videos covering a wide range of oncology specific topics.

George Sledge, MD, shares the most relevant findings from the MONARCH-2 trial

Dr. Sledge, Professor and Chief, Division of Oncology, Stanford Cancer Center, Stanford University School of Medicine, shares the most relevant findings from the MONARCH-2 trial investigating abemaciclib plus fulvestrant in women with metastatic hormone receptor-positive, HER2-negative breast cancer

Tags: BreastESMO 2019

Published: 10 October 2019

Recent Videos

video

Rana McKay, MD, shares results of the randomized Phase 2 study investigating luPSMA vs cabazitaxel

Dr. McKay, Assistant Professor of Medicine, UCSD, shares the results of the randomized Phase 2 study investigating luPSMA vs cabazitaxel ...

video

Rana McKay, MD, dissects the pros and cons of the virtual format of ASCO20

Dr. McKay, Assistant Professor of Medicine, UCSD, dissects the pros and cons of the virtual format of ASCO20 and some ...

video

Rana McKay, MD, elaborates on the advent of hormonal agents for patients with metastatic prostate cancer

Dr. McKay, Assistant Professor of Medicine, UCSD, elaborates on how the advent of hormonal agents for patients with metastatic prostate ...

video

Rana McKay MD, explains approach to treating 2nd-line RCC patients who have received I-O combination

Dr. McKay, Assistant Professor of Medicine, UCSD, explains approach to treating 2nd-line renal cell carcinoma (RCC) patients who have received ...

video

Rana McKay, MD, discusses the design and outcomes of the Phase 3 randomized Keynote 426 study in 1st line clear cell renal cell cancer (RCC)

Dr. McKay, Assistant Professor of Medicine, UCSD, discusses the design and outcomes of the Phase 3 randomized Keynote 426 study ...

video

Rana McKay, MD, shares the design and outcomes of the Javelin Bladder 100 study

Dr. McKay, Assistant Professor of Medicine, UCSD, shares the design and outcomes of the Javelin Bladder 100 study investigating maintenance ...

video

Robert Coleman, MD, describes experience with virtual ASCO20

Dr. Coleman, Chief Scientific Officer, US Oncology Network, describes experience with virtual ASCO20

video

Joyce Liu, MD, describes experience with virtual ASCO20

Dr. Liu, Assistant Professor of Medicine, Dana-Farber Cancer Institute, describes experience with virtual ASCO20

video

Sara Hurvitz, MD, describes the recently reported results using PARP inhibition and cisplatin

Dr. Hurvitz, Associate Professor, David Geffen School of Medicine, describes the recently reported results using PARP inhibition with and without ...

video

Sara Hurvitz, MD, discusses the recently announced results of Monarch E and PALLAS adjuvant trials

Dr. Hurvitz, Associate Professor, David Geffen School of Medicine, discusses the recently announced results of both the Monarch E ...

Related Videos

video-image

Rana McKay MD, explains approach to treating 2nd-line RCC patients who have received I-O combination

video-image

Rana McKay, MD, elaborates on the advent of hormonal agents for patients with metastatic prostate cancer

video-image

Rana McKay, MD, dissects the pros and cons of the virtual format of ASCO20

video-image

Rana McKay, MD, shares results of the randomized Phase 2 study investigating luPSMA vs cabazitaxel

video-image

Rana McKay, MD, shares the design and outcomes of the Javelin Bladder 100 study

video-image

Rana McKay, MD, discusses the design and outcomes of the Phase 3 randomized Keynote 426 study in 1st line clear cell renal cell cancer (RCC)

video-image

Joyce Liu, MD, describes experience with virtual ASCO20

video-image

Robert Coleman, MD, describes experience with virtual ASCO20

video-image

Sara Hurvitz, MD, shares design and outcomes of the HER2CLIMB study in advanced breast cancer

video-image

Sara Hurvitz, MD, discusses the recently announced results of Monarch E and PALLAS adjuvant trials

video-image

Sara Hurvitz, MD, describes the recently reported results using PARP inhibition and cisplatin

video-image

Debu Tripathy, MD, discusses recent FDA approvals and HER2+ metastatic breast cancer management

video-image

Debu Tripathy, MD, on presentations pertaining to immunotherapy in early breast cancer treatment

video-image

Debu Tripathy, MD, introduces new information onCDK4/6 inhibitors discussed at ASCO20

video-image

Debu Tripathy, MD, describes the evolving role of PARP inhibitors in breast cancer patients

video-image

Dana Chase, MD, FACOG, summarizes the outcomes of the NRG-GY004 phase III study in ovarian cancer

video-image

Dana Chase, MD, FACOG, on interpretations of the overall survival results of the Phase 3 SOLO2 study

video-image

Dana Chase, MD, FACOG, provides thoughts on the clinical evidence of secondary cytoreductive surgery

video-image

Dana Chase, MD, FACOG, shares thoughts on the role of I-O in GTT management

video-image

Toni Choueiri, MD, describes treatment strategies for 2nd line renal cell carcinoma